- Home
- VYGR vs NPWR Comparison
VYGR vs NPWR Comparison
Compare VYGR & NPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- NPWR
- Stock Information
- Founded
- VYGR 2013
- NPWR 2010
- Country
- VYGR United States
- NPWR United States
- Employees
- VYGR N/A
- NPWR N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- NPWR Industrial Machinery/Components
- Sector
- VYGR Health Care
- NPWR Energy
- Exchange
- VYGR Nasdaq
- NPWR Nasdaq
- Market Cap
- VYGR 164.3M
- NPWR 148.7M
- IPO Year
- VYGR 2015
- NPWR N/A
- Fundamental
- Price
- VYGR $3.20
- NPWR $3.23
- Analyst Decision
- VYGR Strong Buy
- NPWR Buy
- Analyst Count
- VYGR 8
- NPWR 2
- Target Price
- VYGR $14.33
- NPWR $4.00
- AVG Volume (30 Days)
- VYGR 715.4K
- NPWR 2.2M
- Earning Date
- VYGR 08-05-2025
- NPWR 08-11-2025
- Dividend Yield
- VYGR N/A
- NPWR N/A
- EPS Growth
- VYGR N/A
- NPWR N/A
- EPS
- VYGR N/A
- NPWR N/A
- Revenue
- VYGR $66,958,000.00
- NPWR $250,000.00
- Revenue This Year
- VYGR N/A
- NPWR $308.00
- Revenue Next Year
- VYGR $78.88
- NPWR $1,811.08
- P/E Ratio
- VYGR N/A
- NPWR N/A
- Revenue Growth
- VYGR N/A
- NPWR 100.00
- 52 Week Low
- VYGR $2.65
- NPWR $1.48
- 52 Week High
- VYGR $9.55
- NPWR $14.28
- Technical
- Relative Strength Index (RSI)
- VYGR 51.88
- NPWR 61.11
- Support Level
- VYGR $2.83
- NPWR $2.36
- Resistance Level
- VYGR $3.43
- NPWR $2.64
- Average True Range (ATR)
- VYGR 0.19
- NPWR 0.20
- MACD
- VYGR 0.01
- NPWR 0.02
- Stochastic Oscillator
- VYGR 55.22
- NPWR 98.05
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.